NASDAQ · Medical - Care Facilities
DCGO (DCGO) Stock
$0.65
+2.91%
NASDAQ: DCGO
Healthcare
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
DocGo Launches Mobile Phlebotomy Services in South Florida
Business Wire · Jun 3, 2026
How The DocGo (DCGO) Story Is Shifting As Transport Optimism Meets Lower Valuation Targets
Simply Wall St. · May 16, 2026
DocGo Targets Profitability as It Pivots to Mobile Health, Medical Transport
MarketBeat · May 16, 2026
US$1.87: That's What Analysts Think DocGo Inc. (NASDAQ:DCGO) Is Worth After Its Latest Results
Simply Wall St. · May 14, 2026
DocGo Inc (DCGO) Q1 2026 Earnings Call Highlights: Strong Revenue Growth Amid Operational Challenges
GuruFocus.com · May 12, 2026
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Insiders Held3.07%
Institutions Held43.52%
Institutions Float Held44.90%
Peer Comparison
About DCGO
DCGO is led by CEO Lee Bienstock, employs 3,404 people, headquartered in US, publicly traded since 2020.
DCGO stock trades at $0.65 with a market capitalization of $64.18M. The stock is valued at a price-to-earnings (P/E) ratio of -0.33, price-to-book of 0.42, price-to-sales of 0.20. Over the past 52 weeks the stock has ranged between $0.46 and $1.78, and currently trades 63.5% below its 52-week high.
On profitability, DCGO generates a return on equity (ROE) of -126.39%, return on capital employed of -70.63%, an operating margin of -27.64%, a net profit margin of -62.23%.